North America Healthcare Cold Chain Logistics Market Size, Share, Growth, Top Companies, and Report 2023-2028
The latest report by IMARC Group, titled “North America Healthcare Cold Chain Logistics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the healthcare cold chain logistics market in North America. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The North America healthcare cold chain logistics market size reached US$ 6.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
Healthcare cold chain logistics refers to the service that is adopted for temperature-controlled packaging, storage beyond sub-zero temperatures, and transportation of temperature-sensitive products. It aids in sustaining the integrity, effectiveness, and shelf life of products, such as vaccines, biopharmaceutical items, and supplies for clinical trials, including medications and blood and tissue samples. It utilizes dry ice, liquid nitrogen, and gel packs for preservation and involves the usage of cold-insulated transport vehicles, including refrigerated trucks, railcars, freight, and air cargo, that maintain the effectiveness of the products. Additionally, it provides reliable information to pharmaceutical companies about the products when communicating with regulatory agencies and reduces losses from damaged biomedical products.
Request Free Sample Report: https://www.imarcgroup.com/north-america-healthcare-cold-chain-logistics-market/requestsample
Market Trends:
The rising demand for pharmaceutical drugs is driving the market across North America. This can be attributed to the rising prevalence of infectious and chronic disorders among the masses. Moreover, the increasing reliance on healthcare cold chain logistics to store vaccines under controlled temperatures is contributing to the market. Furthermore, numerous major companies are focussing on developing advanced technologies for improved preservation, extended shelf life, and optimal product safety, which is creating a positive market outlook. Besides this, the implementation of stringent regulations by the governments for the efficient handling of temperature-sensitive pharma products, is further providing an impetus to the market. Other factors, such as the continuous expansion of healthcare infrastructure and extensive research and development (R&D) activities, are also influencing the market across North America.
Explore the Full Report with TOC & List of Figures: https://www.imarcgroup.com/north-america-healthcare-cold-chain-logistics-market
Key Market Segmentation:
Breakup by Product:
- Biopharmaceuticals
- Vaccines
- Clinical Trials
Breakup by Segment:
- Transportation
- Packaging
- Instrumentation
Competitive Landscape with key players:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Key highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
TOC for the Report:
- Preface
- Scope and Methodology
- Executive Summary
- Introduction
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Latest Research Reports by IMARC Group:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
